Etha Articles and Research
ETHA Research and Development (R&D) Research and Development (R&D) The ETHA Research and Development (R&D) team never stops working on new concepts, products and projects. Our tireless pursuit for superior quality is one of the crucial characteristics that sets ETHA apart. We...
Continue reading
Opioid related deaths are on the rise in the United States and a safer alternative is desperately needed now more than ever. A study by Johns Hopkins University School of Medicine and Pinney Associates on October 29th, 2022, revealed that a plant called mitragyna speciosa (commonly known as kratom) and its predominate alkaloid, mitragynine, offer a potentially safer alternative to pharmaceutical opioids. The study revealed that mitragynine has very low respiratory effects even at extremely high doses. Respiratory depression or the slowdown of one’s breathing is one of the major causes of death with opioid use. With over 22 billion dollars on the line for Big Pharmaceuticals (“Big Pharma”) through opioid sales, there can be little doubt that kratom is Big Pharma’s worst nightmare.
Continue reading
Kratom Research: Study outlines the scientific findings on the very low respiratory effects (effects on breathing) of mitragynine when in its natural, non-adulterated state.
Continue reading
